Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025

OBJECTIVE: Rare diseases are life-threatening, debilitating, or serious chronic conditions that affect < 50/100,000 people. Canadians can only access approximately 60% of drugs for rare diseases (DRDs), which is partially related to high per-patient costs and payers’ affordability concerns. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lech, Richard, Chow, Gideon, Mann, Kamalpreet, Mott, Patrick, Malmberg, Christine, Forte, Lindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548177/
https://www.ncbi.nlm.nih.gov/pubmed/36209128
http://dx.doi.org/10.1186/s13023-022-02534-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548177/
https://www.ncbi.nlm.nih.gov/pubmed/36209128
http://dx.doi.org/10.1186/s13023-022-02534-z

Ejemplares similares